S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Laser breakthrough could send stock soaring 2,467% (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NYSE:AFTR

AfterNext HealthTech Acquisition (AFTR) Competitors

$10.34
+0.02 (+0.19%)
(As of 06/6/2023 ET)
Compare
Today's Range
$10.34
$10.38
50-Day Range
$10.22
$10.34
52-Week Range
$9.64
$10.60
Volume
1,331 shs
Average Volume
39,276 shs
Market Capitalization
$323.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AFTR vs. JGGC, FWAC, BYN, CPUH, RRAC, CLIN, HWEL, STET, NRAC, and MTAL

Should you be buying AfterNext HealthTech Acquisition stock or one of its competitors? The main competitors of AfterNext HealthTech Acquisition include Jaguar Global Growth Co. I (JGGC), Fifth Wall Acquisition Corp. III (FWAC), Banyan Acquisition (BYN), Compute Health Acquisition (CPUH), Rigel Resource Acquisition (RRAC), Clean Earth Acquisitions (CLIN), Healthwell Acquisition Corp. I (HWEL), ST Energy Transition I (STET), Northern Revival Acquisition (NRAC), and Metals Acquisition (MTAL). These companies are all part of the "holding & other investment offices" industry.

AfterNext HealthTech Acquisition vs.

Jaguar Global Growth Co. I (NASDAQ:JGGC) and AfterNext HealthTech Acquisition (NYSE:AFTR) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jaguar Global Growth Co. I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
AfterNext HealthTech Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Jaguar Global Growth Co. I's return on equity of -63.27% beat AfterNext HealthTech Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Jaguar Global Growth Co. I N/A -63.27% 2.62%
AfterNext HealthTech Acquisition N/A -69.76% 3.21%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jaguar Global Growth Co. IN/AN/A$5.61 millionN/AN/A
AfterNext HealthTech AcquisitionN/AN/A$10.23 millionN/AN/A

Jaguar Global Growth Co. I and AfterNext HealthTech Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Jaguar Global Growth Co. IN/AN/A
AfterNext HealthTech AcquisitionN/AN/A

70.4% of Jaguar Global Growth Co. I shares are owned by institutional investors. Comparatively, 74.7% of AfterNext HealthTech Acquisition shares are owned by institutional investors. 0.4% of Jaguar Global Growth Co. I shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Jaguar Global Growth Co. I's average media sentiment score of 0.00 equaled AfterNext HealthTech Acquisition's average media sentiment score.

Company Overall Sentiment
Jaguar Global Growth Co. I Neutral
AfterNext HealthTech Acquisition Neutral

Summary

AfterNext HealthTech Acquisition beats Jaguar Global Growth Co. I on 3 of the 5 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFTR vs. The Competition

MetricAfterNext HealthTech AcquisitionHolding Offices IndustryUnclassified SectorNYSE Exchange
Market Cap$323.13M$293.10M$195.19M$14.80B
Dividend YieldN/A9.18%N/A3.99%
P/E RatioN/A1.751.4620.23
Price / SalesN/A7.040.419.13
Price / Cash31.5355.2456.1715.87
Price / Book-29.5481.09223.917.01
Net Income$10.23M$11.25M$9.04M$897.85M
7 Day Performance0.29%0.25%0.59%4.91%
1 Month Performance0.68%0.94%0.94%3.11%
1 Year Performance6.93%1.99%2.81%-7.96%

AfterNext HealthTech Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JGGC
Jaguar Global Growth Co. I
0 of 5 stars
$10.53
+0.3%
N/A+6.5%$322.92MN/A0.00N/AHigh Trading Volume
FWAC
Fifth Wall Acquisition Corp. III
0 of 5 stars
$10.82
-4.2%
N/A+11.1%$323.84MN/A0.002News Coverage
Gap Down
BYN
Banyan Acquisition
0 of 5 stars
$10.32
+0.2%
N/A+3.9%$324.05MN/A0.00N/A
CPUH
Compute Health Acquisition
0 of 5 stars
$10.57
-0.1%
N/A+7.6%$324.98MN/A0.002
RRAC
Rigel Resource Acquisition
0 of 5 stars
$10.66
flat
N/A+6.9%$319.80MN/A0.002,021
CLIN
Clean Earth Acquisitions
0 of 5 stars
$10.40
+0.1%
N/A+6.2%$328.22MN/A0.00N/A
HWEL
Healthwell Acquisition Corp. I
0 of 5 stars
$10.24
+0.2%
N/A+5.6%$329.63MN/A0.002,021
STET
ST Energy Transition I
0 of 5 stars
$10.48
flat
N/AN/A$316.37MN/A30.822,021
NRAC
Northern Revival Acquisition
0 of 5 stars
$10.40
flat
N/A+6.0%$313.98MN/A0.00N/A
MTAL
Metals Acquisition
0 of 5 stars
$10.04
-3.9%
N/A+1.4%$332.73MN/A0.002,021

Related Companies and Tools

This page (NYSE:AFTR) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -